首页> 外文期刊>Journal of Alzheimer's disease: JAD >AD8-Brazil: cross-cultural validation of the ascertaining dementia interview in Portuguese.
【24h】

AD8-Brazil: cross-cultural validation of the ascertaining dementia interview in Portuguese.

机译:AD8-巴西:葡萄牙语确定性痴呆访谈的跨文化验证。

获取原文
获取原文并翻译 | 示例
           

摘要

Dementia is a global public health problem and detection in the primary care setting, particularly in developing countries, is challenging. The aim of this research was to produce the cross-cultural validation of the AD8 interview to the Brazilian Portuguese Language. The original version of the AD8 was submitted to translation, back-translation, and application of the questionnaire to 20 elderly informants for face validation. The AD8-Brazil was then evaluated in 109 community-dwelling elderly with a sociodemographic questionnaire, clinical examination, Mini Mental State Examination (MMSE), Katz Inventory of Activities of Daily Living (ADL), and Clinical Dementia Rating scale (CDR). The AD8-Brazil was compared with the other instruments and with the clinical diagnosis (DSM-IV) for criterion validation. There was significant agreement of AD8-Brazil with diagnosis of dementia (p < 0.001), MMSE (p = 0.047), and ADL (PFisher = 0.004). Also, the AD8-Brazil was able to differentiate the stages of dementia by CDR scale. The reliability was high (alpha = 0.818) and reproducibility analysis showed excellent inter-rater (kappa = 0.889) and test-retest consistency (kappa = 0.814). The AD8-Brazil showed excellent discrimination between CDR 0 and CDR > 0 (area under the curve 86.1%) and between CDR 0 and CDR 0.5 (area under the curve 76.9%). The administration of the questionnaire took 2.3 +/- 0.1 minutes. The Brazilian version of the AD8 is a valid, reliable, quick, and easy screening instrument for dementia.
机译:痴呆症是一个全球性的公共卫生问题,尤其是在发展中国家,在初级保健环境中进行检出具有挑战性。这项研究的目的是对AD8采访巴西葡萄牙语进行跨文化验证。 AD8的原始版本已提交翻译,回译,并向20位年长的线人提供了问卷调查表以进行面部验证。然后,对109位社区居民的老年人进行了社会人口统计学调查表,临床检查,迷你精神状态检查(MMSE),Katz日常生活活动量表(ADL)和临床痴呆症评定量表(CDR),对AD8-巴西进行了评估。将AD8-巴西与其他仪器和临床诊断(DSM-IV)进行了标准验证。 AD8-巴西与痴呆的诊断(p <0.001),MMSE(p = 0.047)和ADL(PFisher = 0.004)有显着一致性。同样,AD8-巴西能够通过CDR量表区分痴呆的阶段。可靠性高(alpha = 0.818),重现性分析显示出色的内部评估者(kappa = 0.889)和重测一致性(kappa = 0.814)。 AD8-巴西在CDR 0和CDR> 0(曲线下面积为86.1%)以及CDR 0和CDR 0.5(曲线下面积为76.9%)之间显示出出色的区分度。问卷的管理耗时2.3 +/- 0.1分钟。巴西版的AD8是一种有效,可靠,快速且简便的痴呆症筛查仪器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号